We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+8.33%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$518B
AUM Growth
+$24.3B
Cap. Flow
-$1.52B
Cap. Flow %
-0.29%
Top 10 Hldgs %
29.53%
Holding
15,731
New
1,614
Increased
6,434
Reduced
5,866
Closed
1,611

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$555M
2
C icon
Citigroup
C
+$407M
3
MDT icon
Medtronic
MDT
+$401M
4
CMG icon
Chipotle Mexican Grill
CMG
+$392M
5
GILD icon
Gilead Sciences
GILD
+$362M

Sector Composition

Rank Sector Weight
1 Technology 3.02%
2 Healthcare 2.92%
3 Consumer Discretionary 2.17%
4 Financials 2.1%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OMGA
13301
CALL
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$7.2K ﹤0.01%
5,900
-11,400
-66% -$18.2K
LCUT icon
13302
CALL
Lifetime Brands
LCUT
$226M
$7.19K ﹤0.01%
1,100
-2,000
-65% -$14.7K
ABOS icon
13303
CALL
Acumen Pharmaceuticals
ABOS
$193M
$7.19K ﹤0.01%
2,900
-1,100
-28% -$2.98K
NBP
13304
PUT
NovaBridge Biosciences American Depositary Shares
NBP
$227M
$7.19K ﹤0.01%
5,800
+3,900
+205% +$4.88K
ORIC icon
13305
PUT
Oric Pharmaceuticals
ORIC
$1.44B
$7.17K ﹤0.01%
+700
New +$6.92K
TROO icon
13306
CALL
TROOPS Inc
TROO
$243M
$7.16K ﹤0.01%
+2,100
New +$7.73K
BORR
13307
CALL
Borr Drilling
BORR
$1.37B
$7.14K ﹤0.01%
1,300
ELS icon
13308
PUT
Equity Lifestyle Properties
ELS
$12.7B
$7.13K ﹤0.01%
100
-74,800
-100% -$5.24M
EVEX icon
13309
Eve Holding
EVEX
$951M
$7.12K ﹤0.01%
2,197
-6,185
-74% -$18.7K
TBI
13310
PUT
Trueblue
TBI
$311M
$7.1K ﹤0.01%
900
+800
+800% +$7.2K
INVE icon
13311
CALL
Identive
INVE
$64.1M
$7.06K ﹤0.01%
2,000
+1,900
+1,900% +$6.95K
AKR icon
13312
PUT
Acadia Realty Trust
AKR
$2.86B
$7.04K ﹤0.01%
300
-400
-57% -$8.53K
DHT icon
13313
DHT Holdings
DHT
$3.14B
$7.04K ﹤0.01%
638
-228,194
-100% -$2.52M
LXP icon
13314
PUT
LXP Industrial Trust
LXP
$3.57B
$7.04K ﹤0.01%
140
-60
-30% -$3K
KNDI
13315
PUT
Kandi Technologies Group
KNDI
$63M
$7K ﹤0.01%
3,400
-9,300
-73% -$16.9K
GDYN icon
13316
PUT
Grid Dynamics Holdings
GDYN
$629M
$7K ﹤0.01%
500
-1,800
-78% -$23.3K
FARM
13317
CALL
DELISTED
Farmer Brothers
FARM
$6.93K ﹤0.01%
3,500
+2,300
+192% +$5.9K
STHO icon
13318
CALL
Star Holdings Shares of Beneficial Interest
STHO
$118M
$6.92K ﹤0.01%
500
-10,600
-95% -$137K
LGO
13319
PUT
Largo
LGO
$74.1M
$6.9K ﹤0.01%
3,300
-500
-13% -$932
NRC icon
13320
CALL
NRC Health Common Stock
NRC
$469M
$6.86K ﹤0.01%
300
+100
+50% +$2.26K
NRC icon
13321
PUT
NRC Health Common Stock
NRC
$469M
$6.86K ﹤0.01%
300
-100
-25% -$2.26K
KYTX icon
13322
CALL
Kyverna Therapeutics
KYTX
$505M
$6.85K ﹤0.01%
1,400
-4,500
-76% -$34.7K
IRS
13323
CALL
IRSA Inversiones y Representaciones
IRS
$1.24B
$6.83K ﹤0.01%
+622
New +$6.11K
SACH
13324
PUT
Sachem Capital Corp
SACH
$37.9M
$6.8K ﹤0.01%
2,700
-2,100
-44% -$5.3K
ACNT icon
13325
CALL
Ascent Industries
ACNT
$136M
$6.79K ﹤0.01%
+700
New +$6.88K

Similar funds

Citadel Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Citadel Advisors's Q3 2024 filing shows 1,614 new, 6,434 increased, 5,866 reduced and 1,611 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
  • Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
  • Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
  • Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
  • Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
  • Citadel Advisors opened 1,614 new positions and closed 1,611 in Q3 2024.
  • Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.